Britannica Sources used in this answer

What is the connection between the Philadelphia chromosome and chronic myelogenous leukemia?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

The impact of the Human Genome Project on cancer research — Human Genome Project The Human Genome Project, which operated from 1990 to 2003, provided researchers with basic information about the genetic content of the human organism, opening new avenues of discovery in fields such as cancer research.

The Philadelphia chromosome is a specific chromosomal abnormality identified in over 90 percent of patients with chronic myelogenous leukemia (CML). It serves as a foundational example of how chromosomal translocation contributes to cancer development.1

This translocation occurs when a segment of chromosome 9 breaks off and joins chromosome 22. Specifically, this process fuses the proto-oncogene c-ABL from chromosome 9 with the breakpoint cluster region (BCR) on chromosome 22. This fusion creates a hybrid oncogene known as BCR-ABL, which encodes a mutant protein that causes aberrant regulation of cellular proliferation. While the precise mechanism remains under study, this protein appears to mimic signaling pathways typically activated by growth factor receptors, thereby driving the uncontrolled cell growth characteristic of leukemia.1

The identification of such genetic drivers has been significantly advanced by the Human Genome Project, which has provided the tools and databases necessary to link specific genomic variations to disease, ultimately fostering the development of personalized medicine.23